"Farmakoterapie" . "1801-1209" . "Inkretinov\u00E1 l\u00E9\u010Dba p\u0159edstavuje v sou\u010Dasn\u00E9 dob\u011B preferovan\u00FD p\u0159\u00EDstup v l\u00E9\u010Db\u011B diabetes mellitus 2 typu d\u00EDky dobr\u00E9 \u00FA\u010Dinnosti, minim\u00E1ln\u00EDmu v\u00FDskytu ne\u017E\u00E1douc\u00EDch \u00FA\u010Dink\u016F a potenci\u00E1ln\u00ED kardioprotektivit\u011B a ochrann\u00E9mu vlivu na beta-bu\u0148ky pankreatu. C\u00EDlem \u010Dl\u00E1nku je shrnout sou\u010Dasn\u00E9 zku\u0161enosti a novinky t\u00FDkaj\u00EDc\u00ED se pou\u017E\u00EDv\u00E1n\u00ED vildagliptinu v l\u00E9\u010Db\u011B diabetu."@cs . . "182554" . "RIV/00064165:_____/12:13273!RIV13-MZ0-00064165" . "RIV/00064165:_____/12:13273" . "Inkretinov\u00E1 l\u00E9\u010Dba p\u0159edstavuje v sou\u010Dasn\u00E9 dob\u011B preferovan\u00FD p\u0159\u00EDstup v l\u00E9\u010Db\u011B diabetes mellitus 2 typu d\u00EDky dobr\u00E9 \u00FA\u010Dinnosti, minim\u00E1ln\u00EDmu v\u00FDskytu ne\u017E\u00E1douc\u00EDch \u00FA\u010Dink\u016F a potenci\u00E1ln\u00ED kardioprotektivit\u011B a ochrann\u00E9mu vlivu na beta-bu\u0148ky pankreatu. C\u00EDlem \u010Dl\u00E1nku je shrnout sou\u010Dasn\u00E9 zku\u0161enosti a novinky t\u00FDkaj\u00EDc\u00ED se pou\u017E\u00EDv\u00E1n\u00ED vildagliptinu v l\u00E9\u010Db\u011B diabetu." . "8" . "Zku\u0161enosti s vildagliptinem v terapii pacient\u016F s diabetes mellitus 2. typu"@cs . "Zku\u0161enosti s vildagliptinem v terapii pacient\u016F s diabetes mellitus 2. typu"@cs . . . . "[68554F60BE45]" . "Zku\u0161enosti s vildagliptinem v terapii pacient\u016F s diabetes mellitus 2. typu" . "Zku\u0161enosti s vildagliptinem v terapii pacient\u016F s diabetes mellitus 2. typu" . . . . "Experiences with vildagliptin in the treatment of patients with type 2 diabetes mellitus"@en . . . "1"^^ . "1"^^ . "Incretin-based therapy represents currently preferred therapeutic option of type 2 diabetes mellitus owing to good efficacy, negligible side effects and potential cardio- and beta-cell-protective effects. The aim of this paper is to review current experience and knowledge concerning the use of vildagliptin in the treatment of diabetes."@en . "Experiences with vildagliptin in the treatment of patients with type 2 diabetes mellitus"@en . "Haluz\u00EDk, Martin" . . . "CZ - \u010Cesk\u00E1 republika" . . . "I" . . . "4" . "6"^^ . "Vildagliptin; type 2 diabetes mellitus; hypoglycemia"@en .